, , , , e.a.

Biomarkers in Cancer Detection and Monitoring of Therapeutics

Volume 2: Diagnostic and Therapeutic Applications

Specificaties
Paperback, blz. | Engels
Elsevier Science | e druk, 2023
ISBN13: 9780323951142
Rubricering
Elsevier Science e druk, 2023 9780323951142
€ 173,80
Levertijd ongeveer 8 werkdagen

Samenvatting

Molecular Biomarkers in Cancer Detection and Monitoring of Therapeutics: Volume Two: Diagnostic and Therapeutic Applications discusses how molecular biomarkers are used to determine predisposition, facilitate detection, improve treatment and offer prevention guidelines for different cancers. It focuses on novel diagnostic techniques based on molecular biomarkers and their impact on treatment, covering different cancer types such as tumors in the nervous system, head and neck, oral and GI tractor, lung, breast, gastric system, leukemia and urogenital tract cancers. For each type, the book discusses the best diagnostic techniques and therapeutic approaches, thus helping readers easily identify the best solution for each case.

This is a valuable resource for cancer researchers, oncologists, graduate students and other members of the biomedical field who are interested in the potential of biomarkers in cancer research.

Specificaties

ISBN13:9780323951142
Taal:Engels
Bindwijze:Paperback

Inhoudsopgave

1. SKIN CANCER BIOLOGY AND ITS BIOMARKERS:RECENT TRENDS AND PROSPECTIVE<br>Himani Sharma<br>2. ROLE OF BIOMARKERS IN ASSESSING RESPONSE TO IMMUNE CHECKPOINT INHIBITORS IN CANCER TREATMENT<br>Shyam Aggarwal<br>3. GENOTYPE INFLUENCED PHARMACOKINETICS OF ANTI-CANCER MEDICINE: A CONNECTING LINK<br>Shamsher Singh<br>4. GENETIC PREDISPOSITION AND PATHOPHYSIOLOGY OF ORAL SQUAMOUS CELL CARCINOMA<br>Gowtham Kumar Subbaraj<br>5. ORAL SQUAMOUS CELL CARCINOMA<br>Anubha Gulati<br>6. SHARED AND DISTINCT ASPECTS OF HEMATOPOIETIC MALIGNANCIES SUCH AS LEUKEMIA AND LYMPHOMA<br>Ramakrishnan Veerabathiran<br>7. MOLECULAR DIAGNOSIS, DRIVERS AND TREATMENT LYMPHOCYTIC LEUKEMIA<br>Saurabh Yadav<br>8. MYELODYSPLASTIC SYNDROME – A CHALLENGING ENTITY<br>Anshu Palta<br>9. MULTIPLE MYELOMA<br>Vijay Goni<br>10. MOLECULAR BIOMARKERS IN PROSTATE CANCER<br>KATSUNORI UCHIDA and Remi Semba<br>11. GENETICS OF NEURONAL AND GLIONEURONAL CANCERS<br>Anshika Srivastava<br>12. RECENT ADVANCEMENT IN MOLECULAR MARKER OF PANCREATIC CANCER<br>Kanagaraj Palaniyandi<br>13. MOLECULAR BIOMARKERS IN GASTRIC CANCER<br>Yoshifumi S. Hirokawa and Kazuki Kanayama<br>14. MOLECULAR BIOMARKERS IN PANCREATIC DUCTAL ADENOCARCINOMA<br>Yoshifumi S. Hirokawa, Reiko Yamada and Junya Tsuboi<br>15. BIOMARKERS IN ENDOMTRIAL AND CERVICAL CANCER<br>Aashima Arora<br>16. BIOMARKERS IN ENDOCRINE DISEASES<br>Sunil Chumber and Dhritiman Maitra<br>17. CANCER IMMUNOTHERAPY ASSOCIATED ENDOCRINE COMPLICATIONS<br>Kousik Pramanick<br>18. THERAPEUTIC POTENTIAL OF MELATONIN IN GLIOBLASTOMA: CURRENT KNOWLEDGE AND FUTURE PROSPECTS<br>Nithar Ranjan Madhu Sr.<br>19. ANTICANCER ACTIVITIES OF MACROMOLECULES OFMARINE ORIGIN: CLINICAL EVIDENCE<br>Maushmi Shailesh Kumar<br>20. NANOPARTICLES AS A MEANS OF DRUG DELIVERY IN CANCER THERAPY<br>Olorunfemi Raphael Molehin<br>21. THERAPEUTIC POTENTIAL OF MICROALGAE AND THEIR PROSPECTS IN TARGETED DELIVERY IN CANCER MANAGEMENT<br>Maushami Kumar and Maushmi Shailesh Kumar<br>22. PROSPECTS OF MANGROVE DERIVED PHYTOCHEMICALS IN CANCER RESEARCH<br>Punarbasu Choawdhury<br>23. PHYTOCHEMICALS AND MIRNA BASED THERAPEUTIC OPPORTUNITIES FOR CANCER STEM CELL MEDIATED TUMOR ANGIOGENESIS<br>Anandan Balakrishnan<br>24. EMERGENCE OF METAL-BASED ANTICANCER THERAPEUTICS: A PROMISING PERSPECTIVE<br>Suman Adhikari<br>25. NEW INFRARED (NIR) RESPONSE NANOMATERIAL LIPOSOME NANOHYBRID FOR CANCER PHOTO THERMAL<br>Animesh Pan<br>26. IMPACT OF PESTICIDES ON IMMUNE-ENDOCRINE DISORDERS AND ITS RELATIONSHIP TO CANCER DEVELOPMENT<br>Carolina Panis
€ 173,80
Levertijd ongeveer 8 werkdagen

Rubrieken

    Personen

      Trefwoorden

        Biomarkers in Cancer Detection and Monitoring of Therapeutics